ClinicalTrials.gov
public full text
Public Domain
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
To determine the safety and efficacy of using the drug azeliragon combined with stereotactic radiosurgery. Specifically, to determine if this combination will lead to improved response in the brain (tumor shrinking in size) and overall tumor control (how long tumor remains controlled).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Measuring and Mapping Cognitive Decline After Brain Radiosurgery#1060688
- Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery#1260590
- a Feasibility Study of iHD-SRT for BM#1087609
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain#1231257
- 18F ML-10 for Early Detection of Response of Brain Metastases to SRS#890198
Record · ID 1443966
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive